Acquisition / mergerMajor developmentFiled on BSE ·

Astral Q1 FY27 consolidated revenue up 15.9%, PAT up 51.8% to Rs. 1,202 million

Astral · Industrial Products

Arthneeti Research DeskPublished 1 min read
₹120 CrAcquisition / merger

Key highlights

  • Q1 2026-27 consolidated revenue from operations was Rs. 15,780 million against Rs. 13,612 million a year earlier; EBIDTA was Rs. 2,440 million (15.5% of net sales) against Rs. 1,940 million.
  • Plumbing revenue rose 10.1% to Rs. 10,505 million, with segment EBIDTA margin of 18.9% and sales of 56,146 M.T. against 56,074 M.T. a year earlier.
  • Astral Chemie Limited signed definitive agreements dated June 11, 2026 for a 60% interest in DSS and paid Rs. 391 million upfront; DSS added sales of Rs. 67 million and EBIDTA of Rs. 9 million.

Why it's rated major development: the year-on-year change is 52% (50% or more)

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Astral

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.